What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Gene
- Disease
Alan Pestronk focuses on Pathology, Immunology, Amyotrophic lateral sclerosis, Internal medicine and Antibody.
Pathology connects with themes related to Muscle weakness in his study.
His Immunology study frequently draws connections between related disciplines such as Weakness.
His work in the fields of Amyotrophic lateral sclerosis, such as Lower motor neuron, intersects with other areas such as Motor conduction block.
His research integrates issues of Endocrinology and Surgery in his study of Internal medicine.
The concepts of his Antibody study are interwoven with issues in Polyneuropathy and Ganglioside.
His most cited work include:
- Inclusion body myopathy associated with Paget disease of bone and frontotemporal dementia is caused by mutant valosin-containing protein. (1064 citations)
- Mutations in prion-like domains in hnRNPA2B1 and hnRNPA1 cause multisystem proteinopathy and ALS (865 citations)
- Abnormal excitatory amino acid metabolism in amyotrophic lateral sclerosis (580 citations)
What are the main themes of his work throughout his whole career to date?
Alan Pestronk mainly focuses on Internal medicine, Pathology, Immunology, Antibody and Myopathy.
He has researched Internal medicine in several fields, including Gastroenterology, Endocrinology and Surgery.
As a member of one scientific family, Alan Pestronk mostly works in the field of Pathology, focusing on Weakness and, on occasion, Creatine kinase and Biopsy.
His Antibody study integrates concerns from other disciplines, such as Polyneuropathy and Ganglioside.
His Myopathy research incorporates themes from Molecular biology and Hereditary inclusion body myopathy.
His research in Amyotrophic lateral sclerosis intersects with topics in Genetics and Motor neuron.
He most often published in these fields:
- Internal medicine (26.03%)
- Pathology (23.56%)
- Immunology (21.92%)
What were the highlights of his more recent work (between 2011-2021)?
- Internal medicine (26.03%)
- Pathology (23.56%)
- Myopathy (12.60%)
In recent papers he was focusing on the following fields of study:
Alan Pestronk spends much of his time researching Internal medicine, Pathology, Myopathy, Dysferlinopathy and Disease.
While the research belongs to areas of Internal medicine, Alan Pestronk spends his time largely on the problem of Gastroenterology, intersecting his research to questions surrounding Nerve fiber.
His Pathology study frequently draws connections to other fields, such as Weakness.
His Myopathy research integrates issues from Exome sequencing, Exome, Distal Myopathies and Hereditary inclusion body myopathy.
His Amyotrophic lateral sclerosis research is multidisciplinary, incorporating perspectives in Genetics, Oncology and Missense mutation.
His Antibody study is concerned with the larger field of Immunology.
Between 2011 and 2021, his most popular works were:
- Mutations in prion-like domains in hnRNPA2B1 and hnRNPA1 cause multisystem proteinopathy and ALS (865 citations)
- An antisense oligonucleotide against SOD1 delivered intrathecally for patients with SOD1 familial amyotrophic lateral sclerosis: A phase 1, randomised, first-in-man study (421 citations)
- Mutations in the Matrin 3 gene cause familial amyotrophic lateral sclerosis (273 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Gene
- Disease
Alan Pestronk mostly deals with Muscular dystrophy, Genetics, Amyotrophic lateral sclerosis, Pathology and Internal medicine.
Alan Pestronk combines subjects such as Duchenne muscular dystrophy and Disease with his study of Muscular dystrophy.
His Amyotrophic lateral sclerosis study combines topics in areas such as Missense mutation, Clinical trial, Tolerability, Age of onset and C9orf72.
His study in Pathology is interdisciplinary in nature, drawing from both Skeletal muscle, Magnetic resonance neurography and Polyradiculoneuropathy.
His Internal medicine study integrates concerns from other disciplines, such as Gastroenterology and Physical therapy.
He interconnects Myasthenia gravis, Immunology, Odds ratio, Case-control study and Single-nucleotide polymorphism in the investigation of issues within Cohort.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
